Nike names David Denton as new CFO; Matthew Friend to depart
Denton, a veteran finance executive from Pfizer and Lowe's, takes over Aug. 17 as Friend transitions out.
By the FiledFeed automated desk
This summary was generated by AI from the company's SEC filing and may contain errors — always verify against the primary source on SEC.gov.
The short version
Nike announced that David M. Denton, the current CFO of Pfizer, will join the company as Chief Financial Officer effective August 17, 2026. Matthew Friend, the current CFO, will step down that day and remain through September 4 to assist with the transition. Nike also noted that its fourth-quarter results will include a one-time benefit from tariff refunds not included in prior guidance.
Filing impact
Filing sentiment
Nike has announced a planned transition in its financial leadership, naming David M. Denton as the incoming Chief Financial Officer effective August 17, 2026. Matthew Friend, the current CFO, will step down on that date but remain as an advisor through September 4 to help ensure a smooth handoff.
Denton joins Nike from Pfizer, where he has served as CFO and Executive Vice President since May 2022. He brings more than 30 years of finance and operating leadership experience at large, complex public companies. Before Pfizer, he was CFO of Lowe's Companies from 2018 to 2022, overseeing finance and strategy. Earlier in his career, he spent two decades at CVS Health Corporation, including a stint as Executive Vice President and CFO. Denton has also served on the boards of directors of Haleon (2023–2024) and Tapestry (2014–2023), and is expected to join the Board of Honeywell Aerospace following its planned spin-off from Honeywell.
CEO Elliott Hill said Denton's experience and "operating rigor" will help Nike execute its priorities with consistency. Hill added that the transition is well-timed as Nike moves from foundational work to sustained growth under its new operating model.
Friend will step down from his CFO role as planned and stay on as a non-executive employee during the transition period. He will participate in Nike's fourth-quarter earnings call on June 30 as originally scheduled. Under a transition agreement signed June 17, Friend will receive a one-time payment of $2 million in connection with his transition assistance, along with severance benefits and equity treatment in line with Nike's executive severance plan. His non-compete agreement remains in effect.
Nike also said its fourth-quarter fiscal 2026 results, due June 30, will include a benefit from tariff refunds that was not in the company's prior guidance. Excluding this one-time item, results are expected to be in line with previously provided guidance.
Why it matters
CFO transitions can signal internal shifts in strategy or priorities; this one comes as Nike moves toward a new operating model under CEO Elliott Hill. Denton's track record at Pfizer, Lowe's, and CVS—companies managing major operational transformations—may indicate Nike is emphasizing financial discipline and operational efficiency. The one-time tariff-refund benefit noted in the filing is a positive, though isolated, item that won't repeat. The $2 million transition payment and severance package for Friend suggest a planned, amicable departure, which reduces near-term execution risk around the handoff.
Frequently asked
- When does the new CFO take over?
- David M. Denton will join Nike as CFO effective August 17, 2026. Matthew Friend will step down that same day but remain as an advisor through September 4 to help with the transition.
- Who is David Denton and where did he come from?
- Denton is currently the CFO and Executive Vice President of Pfizer, a role he has held since May 2022. Before that, he was CFO of Lowe's Companies (2018–2022) and spent two decades at CVS Health Corporation, including as CFO. He has more than 30 years of finance leadership experience at large public companies.
- Is Matthew Friend receiving severance?
- Yes. Friend will receive a one-time payment of $2 million as a transition benefit for assisting with the handoff, plus severance benefits in accordance with Nike's executive severance plan, subject to signing a release of claims.
- Will the earnings being reported on June 30 be affected?
- Nike's fourth-quarter results coming June 30 will include a one-time benefit from tariff refunds. Excluding that item, fourth-quarter results are expected to be in line with previously provided guidance.
What the filing reported
- 2.02 Results of Operations & Financial Condition
- 5.02 Departure/Election of Directors or Officers
- 7.01 Regulation FD Disclosure
- 9.01 Financial Statements & Exhibits
Source
Based on NIKE, Inc.'s 8-K filed with the SEC on Jun 23, 2026. Read the original filing on SEC.gov ↗